Also known as: Vyvanse (US, Canada) · Venvanse (parts of EU) · lisdexamfetamine (generic)
Elvanse (lisdexamfetamine) is one of the most commonly prescribed ADHD medications in the UK. A long-acting amphetamine prodrug your body activates gradually, producing a smoother onset and longer coverage than many alternatives.
Elvanse is a prodrug your body activates gradually. Unlike immediate-release stimulants that enter your bloodstream directly, lisdexamfetamine must be converted by enzymes (primarily in red blood cells) into dextroamphetamine before it becomes active. This conversion happens steadily through the morning, which is what gives Elvanse its characteristically smooth onset and extended duration.
After you take your dose, levels begin to rise. Most people notice the onset within the first one to two hours, though peak concentration is reached around three to four hours after dosing. From that peak, levels decline steadily through the afternoon and evening.
This rise-and-fall profile means your experience of the medication changes throughout the day. The morning may feel different from the afternoon. Understanding where you are in that cycle at any given moment can help you plan around it rather than react to it.
Why a prodrug? The prodrug design provides two practical benefits beyond pharmacology: it cannot be inhaled or injected to produce a faster effect (the body still has to do the conversion), and the conversion rate is relatively consistent across individuals, which makes the dose-response more predictable.
Elvanse is one of three amphetamine-based ADHD medications you might encounter. They share a molecule but differ in how they deliver it.
UK Elvanse titration typically starts at 30mg and increases in steps to 50mg, then 70mg, based on how you respond. Each dose level is usually maintained for at least two to four weeks before review. Titration can take several months depending on response and appointment availability. Your prescriber adjusts up or down based on focus, side effects, sleep, and appetite.
Available UK doses: 20mg, 30mg, 40mg, 50mg, 60mg, 70mg.
Most people take Elvanse first thing in the morning, soon after waking. The combination of a slow onset (one to two hours to feel it) and a long duration (10 to 14 hours active) means dose timing is the single biggest controllable factor in how the medication interacts with your sleep.
Taking it at 6am rather than 9am moves your wind-down window three hours earlier in the day. ADHDose models this exact relationship, showing you how your dose timing translates into the time your levels drop below your individual sleep threshold. See Best time to take Elvanse and Does Elvanse affect sleep? for the practical guides.
Elvanse can be taken with or without food. Taking it with breakfast may slightly delay the onset (around 30 minutes) but does not reduce the overall effect. Many people prefer to take it with food during the first few weeks to reduce stomach discomfort. High-fat meals do not significantly affect absorption.
ADHDose models your Elvanse concentration curve hour by hour using the published pharmacokinetic profile, calibrated to your dose, your morning timing and your individual metabolism. The app translates that curve into real-time guidance on where you are in your day, when your medication will start to clear for sleep, and what patterns are emerging across the weeks. The Clinician Summary export pulls 28 days of data into a structured PDF in NHS prescriber format for your reviews.
Elvanse rises gradually, reaches peak around four hours after dosing, then declines through the afternoon and evening. The exact shape depends on your dose, your metabolism, what you ate, and what time you took it. ADHDose calculates that curve for you and updates it through your day.
The app reads your prescription, calibrates to your individual response and shows you exactly where you are in your medication day, minute by minute. The Clinician Summary export pulls 28 days of patterns into NHS prescriber format for your reviews.
Most people tolerate Elvanse well, especially after the first few weeks. Here are the patterns worth noticing — and the ones that warrant a call to your prescriber.
Most ease in the first two to four weeks. Logging them daily helps you and your prescriber decide whether they are settling or sticking.
Not emergencies, but worth bringing up. ADHDose tags recurring patterns automatically in your daily logs.
Rare, but worth knowing. If you see any of these, contact your prescriber rather than stopping on your own.
The first weeks of Elvanse have a recognisable shape. Knowing what is normal at each stage stops you reading too much into a single bad day.
Most people feel something within the first hour or two of the first dose. The first few days often involve small wobbles — appetite changes, sleep shifts, occasional headaches. None of this is unusual. Daily logging helps separate first-dose nerves from real side effect patterns.
Side effects from days one to three usually start to ease. The dose-response becomes more predictable. Track focus, sleep and energy daily. This is the data your prescriber wants at your first review.
Most UK protocols schedule the first review around week two or four. Your prescriber will ask about effect, side effects, sleep and appetite. Bringing tracked data — rather than relying on memory — turns the review from vague impressions into something concrete.
If 30mg is not quite right, your prescriber will increase to 50mg, then potentially 70mg. Each step is held for two to four weeks before review. The same daily logging continues across each step.
Once your dose is settled, reviews shift to every six to twelve months. Daily logging becomes lighter — focus and sleep are usually enough. The Clinician Summary export gives prescribers a 28-day window of evidence at each review.
ADHDose makes the milestone view concrete. Daily logs of focus, sleep, energy and side effects across the titration window show the trajectory clearly — to you, and to your prescriber when review day arrives.